VERNALIS Trademark

Trademark Overview


On Wednesday, April 8, 2015, a trademark application was filed for VERNALIS with the United States Patent and Trademark Office. The USPTO has given the VERNALIS trademark a serial number of 86591321. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Friday, June 10, 2022. This trademark is owned by Vernalis Development Limited. The VERNALIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction...

Scientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product eva...
vernalis

General Information


Serial Number86591321
Word MarkVERNALIS
Filing DateWednesday, April 8, 2015
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateFriday, June 10, 2022
Registration Number4891901
Registration DateTuesday, January 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements


Goods and Services[ Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pasta, breads, cereals, crackers, meat, fruit, vegetables, confectionery, lipids in the nature of margarine, butter substitute, lard, fish oil, butter, peanut oil, soya bean oil, sunflower oil, sesame oil, coconut oil, olive oil, animal-derived fats and oils, plant-derived oils and dairy products in the nature of cheese, milk, butter, yoghurt, cream, and curds, all adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders ]
Goods and ServicesScientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluation, development and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateFriday, June 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 16, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVERNALIS (R&D) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressCAMBRIDGE CB216GB
GB

Party NameVernalis Development Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge CB216GB

Party NameVernalis Development Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkshire RG415RD
GB

Party NameVernalis Development Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkshire RG415RD
GB

Trademark Events


Event DateEvent Description
Friday, June 10, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, June 10, 2022REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, June 10, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 21, 2021TEAS SECTION 8 & 15 RECEIVED
Monday, August 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 30, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 16, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 26, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 5, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 1, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, October 1, 2015ASSIGNED TO LIE
Thursday, October 1, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 1, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, October 1, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, September 25, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 25, 2015NON-FINAL ACTION E-MAILED
Friday, September 25, 2015NON-FINAL ACTION WRITTEN
Friday, September 4, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 23, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 23, 2015NON-FINAL ACTION E-MAILED
Thursday, July 23, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 15, 2015ASSIGNED TO EXAMINER
Thursday, April 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 11, 2015NEW APPLICATION ENTERED IN TRAM